[Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology].
Dirk Koschel, Jürgen Behr, Melanie Berger, Francesco Bonella, Okka Hamer, Marcus Joest, Danny Jonigk, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Monika Raulf, Beate Rehbock, Jens Schreiber, Helmut Sitter, Dirk Theegarten, Ulrich Costabel
{"title":"[Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology].","authors":"Dirk Koschel, Jürgen Behr, Melanie Berger, Francesco Bonella, Okka Hamer, Marcus Joest, Danny Jonigk, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Monika Raulf, Beate Rehbock, Jens Schreiber, Helmut Sitter, Dirk Theegarten, Ulrich Costabel","doi":"10.1055/a-2369-8458","DOIUrl":null,"url":null,"abstract":"<p><p>Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) in sensitized individuals caused by a large variety of inhaled antigens. The clinical form of acute HP is often misdiagnosed, while the chronic form, especially the chronic fibrotic HP, is difficult to differentiate from other fibrotic ILDs. The present guideline for the diagnosis and treatment of HP replaces the former German recommendations for the diagnosis of HP from 2007 and is amended explicitly by the issue of the chronic fibrotic form, as well as by treatment recommendations for the first time. The evidence was discussed by a multidisciplinary committee of experts. Then, recommendations were formulated for twelve questions on important issues of diagnosis and treatment strategies. Recently published national and international guidelines for ILDs and HP were considered. Detailed background information on HP is useful for a deeper insight into HP and the handling of the guideline.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2369-8458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) in sensitized individuals caused by a large variety of inhaled antigens. The clinical form of acute HP is often misdiagnosed, while the chronic form, especially the chronic fibrotic HP, is difficult to differentiate from other fibrotic ILDs. The present guideline for the diagnosis and treatment of HP replaces the former German recommendations for the diagnosis of HP from 2007 and is amended explicitly by the issue of the chronic fibrotic form, as well as by treatment recommendations for the first time. The evidence was discussed by a multidisciplinary committee of experts. Then, recommendations were formulated for twelve questions on important issues of diagnosis and treatment strategies. Recently published national and international guidelines for ILDs and HP were considered. Detailed background information on HP is useful for a deeper insight into HP and the handling of the guideline.
过敏性肺炎(HP)是由多种吸入性抗原引起的免疫介导的间质性肺疾病(ILD)。临床上,急性过敏性肺炎经常被误诊,而慢性过敏性肺炎,尤其是慢性纤维化过敏性肺炎,则很难与其他纤维化 ILD 区分开来。目前的 HP 诊断和治疗指南取代了德国自 2007 年起提出的 HP 诊断建议,并对慢性纤维化型 HP 的问题进行了明确修订,还首次提出了治疗建议。多学科专家委员会对证据进行了讨论。然后,针对诊断和治疗策略方面的 12 个重要问题提出了建议。同时还考虑了最近发布的关于 ILD 和 HP 的国家和国际指南。有关 HP 的详细背景信息有助于深入了解 HP 和处理该指南。
期刊介绍:
Organ der Deutschen Gesellschaft für Pneumologie DGP Organ des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose DZK Organ des Bundesverbandes der Pneumologen BdP Fachärzte für Lungen- und Bronchialheilkunde, Pneumologen und Allergologen